Common communicable diseases in the general population in France during the COVID-19 pandemic
- PMID: 34634090
- PMCID: PMC8504745
- DOI: 10.1371/journal.pone.0258391
Common communicable diseases in the general population in France during the COVID-19 pandemic
Abstract
In France, social distancing measures have been adopted to contain the spread of COVID-19, culminating in national Lockdowns. The use of hand washing, hydro-alcoholic rubs and mask-wearing also increased over time. As these measures are likely to impact the transmission of many communicable diseases, we studied the changes in common infectious diseases incidence in France during the first year of COVID-19 circulation. We examined the weekly incidence of acute gastroenteritis, chickenpox, acute respiratory infections and bronchiolitis reported in general practitioner networks since January 2016. We obtained search engine query volume for French terms related to these diseases and sales data for relevant drugs over the same period. A periodic regression model was fit to disease incidence, drug sales and search query volume before the COVID-19 period and extrapolated afterwards. We compared the expected values with observations made in 2020. During the first lockdown period, incidence dropped by 67% for gastroenteritis, by 79% for bronchiolitis, by 49% for acute respiratory infection and 90% for chickenpox compared to the past years. Reductions with respect to the expected incidence reflected the strength of implemented measures. Incidence in children was impacted the most. Reduction in primary care consultations dropped during a short period at the beginning of the first lockdown period but remained more than 95% of the expected value afterwards. In primary care, the large decrease in reported gastroenteritis, chickenpox or bronchiolitis observed during the period where many barrier measures were implemented imply that the circulation of common viruses was reduced and informs on the overall effect of these measures.
Conflict of interest statement
The authors have read the journal’s policy and have the following competing interests: ML and IB are employees of IQVIA France. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.
Figures





Similar articles
-
Epidemiology of acute gastroenteritis in France from November 2019-August 2021, in light of reported adherence to COVID-19 barrier measures.Sci Rep. 2022 Oct 19;12(1):17504. doi: 10.1038/s41598-022-22317-7. Sci Rep. 2022. PMID: 36261604 Free PMC article.
-
Changes in Emergency Department Activity and the First COVID-19 Lockdown: A Cross-sectional Study.West J Emerg Med. 2021 May 7;22(3):603-607. doi: 10.5811/westjem.2021.2.49614. West J Emerg Med. 2021. PMID: 34125034 Free PMC article.
-
Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.Commun Dis Intell (2018). 2021 Feb 26;45. doi: 10.33321/cdi.2021.45.11. Commun Dis Intell (2018). 2021. PMID: 33632091
-
Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?Expert Rev Vaccines. 2022 Nov;21(11):1541-1553. doi: 10.1080/14760584.2022.2117693. Epub 2022 Sep 5. Expert Rev Vaccines. 2022. PMID: 36039786 Review.
-
[Covid-19, september 2020: fall storm warning].Virologie (Montrouge). 2020 Dec 1;24(6):361-367. doi: 10.1684/vir.2020.0865. Virologie (Montrouge). 2020. PMID: 33252045 Review. French.
Cited by
-
A population database analysis to describe the residual burden of varicella in Italy-a high vaccination coverage area-from 2004 to 2022.Front Public Health. 2025 Mar 3;13:1412620. doi: 10.3389/fpubh.2025.1412620. eCollection 2025. Front Public Health. 2025. PMID: 40098802 Free PMC article.
-
Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand.Hum Vaccin Immunother. 2024 Dec 31;20(1):2367283. doi: 10.1080/21645515.2024.2367283. Epub 2024 Jul 25. Hum Vaccin Immunother. 2024. PMID: 39051458 Free PMC article.
-
Comparison of Elecsys and Liaison immunoassays to determine Epstein-Barr virus serological status using further diagnostic approaches to clarify discrepant results.J Med Virol. 2023 Jan;95(1):e28166. doi: 10.1002/jmv.28166. Epub 2022 Oct 1. J Med Virol. 2023. PMID: 36137986 Free PMC article.
-
Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis.Diabetes Ther. 2024 Jun;15(6):1435-1449. doi: 10.1007/s13300-024-01583-w. Epub 2024 Apr 29. Diabetes Ther. 2024. PMID: 38683494 Free PMC article.
-
Impact assessment of immunization and the COVID-19 pandemic on varicella across Europe using digital epidemiology methods: A descriptive study.PLoS One. 2023 Apr 12;18(4):e0283465. doi: 10.1371/journal.pone.0283465. eCollection 2023. PLoS One. 2023. PMID: 37043422 Free PMC article.
References
-
- Les actions du gouvernement. Available from: https://www.gouvernement.fr/info-coronavirus/les-actions-du-gouvernement n.d.
-
- Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ 2020. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous